Related references
Note: Only part of the references are listed.HMGA2 Overexpression-Induced Ovarian Surface Epithelial Transformation Is Mediated Through Regulation of EMT Genes
Jingjing Wu et al.
CANCER RESEARCH (2011)
Regulation of HMGA1 Expression by MicroRNA-296 Affects Prostate Cancer Growth and Invasion
Jian-Jun Wei et al.
CLINICAL CANCER RESEARCH (2011)
Oncogenic Ras Regulates BRIP1 Expression to Induce Dissociation of BRCA1 from Chromatin, Inhibit DNA Repair, and Promote Senescence
Zhigang Tu et al.
DEVELOPMENTAL CELL (2011)
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer
Shiyu Zhang et al.
GYNECOLOGIC ONCOLOGY (2011)
Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis
Anna Yemelyanova et al.
MODERN PATHOLOGY (2011)
miR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors
Patryk Moskwa et al.
MOLECULAR CELL (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
HMGA2: A Potential Biomarker Complement to P53 for Detection of Early-stage High-grade Papillary Serous Carcinoma in Fallopian Tubes
Jian-Jun Wei et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Molecular Profiling Uncovers a p53-Associated Role for MicroRNA-31 in Inhibiting the Proliferation of Serous Ovarian Carcinomas and Other Cancers
Chad J. Creighton et al.
CANCER RESEARCH (2010)
Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
David C. Corney et al.
CLINICAL CANCER RESEARCH (2010)
Derepression of HMGA2 via Removal of ZBRK1/BRCA1/CtIP Complex Enhances Mammary Tumorigenesis
Kazi Mokim Ahmed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ashour Ahmed Ahmed et al.
JOURNAL OF PATHOLOGY (2010)
The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube
Wa Xian et al.
JOURNAL OF PATHOLOGY (2010)
HMGA2: A biomarker significantly overexpressed in high-grade ovarian serous carcinoma
Aparna Mahajan et al.
MODERN PATHOLOGY (2010)
The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes
Anna-Barbara Stittrich et al.
NATURE IMMUNOLOGY (2010)
Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis
K. Levanon et al.
ONCOGENE (2010)
The genesis and evolution of high-grade serous ovarian cancer
David D. L. Bowtell
NATURE REVIEWS CANCER (2010)
Suppression of Nonhomologous End Joining Repair by Overexpression of HMGA2
Angela Y. J. Li et al.
CANCER RESEARCH (2009)
Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer
Christian Parr et al.
EUROPEAN JOURNAL OF CANCER (2009)
Modulation of microRNA processing by p53
Hiroshi I. Suzuki et al.
NATURE (2009)
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor
Miguel F. Segura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
Joshua Z. Press et al.
BMC CANCER (2008)
HMGA2 and Smads Co-regulate SNAIL1 Expression during Induction of Epithelial-to-Mesenchymal Transition
Sylvie Thuault et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
Keren Levanon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The guardian's little helper: MicroRNAs in the p53 tumor suppressor network
Xingyue He et al.
CANCER RESEARCH (2007)
Differential regulation of microRNAs by p53 revealed by massively parallel Sequencing -: miR-34a is a p53 target that induces apoptosis and G1-arrest
Valery Tarasov et al.
CELL CYCLE (2007)
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Tsung-Cheng Chang et al.
MOLECULAR CELL (2007)
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Y. Lee et al.
JOURNAL OF PATHOLOGY (2007)
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada
Harvey A. Risch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability
K. Gudmundsdottir et al.
ONCOGENE (2006)
The role of BRCA1 in transcriptional regulation and cell cycle control
P. B. Mullan et al.
ONCOGENE (2006)
Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition
Sylvie Thuault et al.
JOURNAL OF CELL BIOLOGY (2006)
The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome
F Medeiros et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
A genetically defined model for human ovarian cancer
JS Liu et al.
CANCER RESEARCH (2004)
Gene expression profiles, of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers
AA Jazaeri et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
MIM, a potential metastasis suppressor gene in bladder cancer
YG Lee et al.
NEOPLASIA (2002)
DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein
H Tran et al.
SCIENCE (2002)
Share Paper
